|1.||Zhao, Ming: 7 articles (04/2011 - 08/2006)|
|2.||Fang, Wei: 6 articles (04/2011 - 08/2006)|
|3.||Wang, Feng: 5 articles (04/2011 - 02/2007)|
|4.||Zhu, Xiaoguang: 5 articles (11/2007 - 08/2006)|
|5.||Brindle, Kevin M: 3 articles (05/2010 - 11/2007)|
|6.||Ji, Shundong: 3 articles (04/2008 - 08/2006)|
|7.||Wang, Zizheng: 2 articles (04/2011 - 04/2008)|
|8.||Neves, Andre A: 2 articles (05/2010 - 03/2008)|
|9.||Kobayashi, Shizuka: 2 articles (05/2008 - 12/2002)|
|10.||Saji, Makoto: 2 articles (05/2008 - 12/2002)|
04/01/2008 - "Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study."
03/01/2008 - "To prospectively determine in an animal model whether an ionic gadolinium (Gd(3+)) chelate conjugate of the C2A domain of synaptotagmin I can be used with magnetic resonance (MR) imaging to detect tumor cell death noninvasively in vivo. "
06/01/2009 - "Further studies will be required to elucidate the mechanism by which Synaptotagmin I plays role in refractory epilepsy."
06/01/2009 - "These findings provide new information in the epileptogenesis of refractory epilepsy, and suggest that Synaptotagmin I might be involved in human refractory epilepsy. "
06/01/2009 - "The expression of Synaptotagmin I in refractory epilepsy group was significantly higher than that in the control and non-refractory epilepsy groups. "
06/01/2009 - "We aimed to investigate Synaptotagmin I expression in the anterior temporal neocortex of epilepsy patients, and to explore the possible role of Synaptotagmin I in refractory epilepsy. "
06/01/2009 - "Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy."
|3.||Myocardial Ischemia (Ischemic Heart Diseases)
03/01/2000 - "Previous studies of pancreatic beta-cells were unable to show presence of synaptotagmin I. We now present biochemical and immunohistochemical data showing that synaptotagmin III is present in pancreatic beta-cells as well as in the insulin-secreting cell line HIT-T15 and in rat insulinoma. "
11/01/2007 - "In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion."
11/01/2007 - "It was recently demonstrated that the radiolabeled C2A domain of synaptotagmin I accumulates avidly in the area at risk after ischemia and reperfusion. "
11/01/2007 - "SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model."
05/01/2008 - "To test the possibility that antisense in vivo knockdown of synaptotagmin I modulates the exocytotic release of glutamate, thus suppressing the excitotoxic intracellular processes leading to neuronal death following ischemia in the neonatal brain, we injected antisense oligodeoxynucleotides (ODNs) targeting synaptotagmin I (0.3 (AS), 0.15 (0.5 AS), or 0.03 microg (0.1 AS), or vehicle) into the lateral ventricles of 7-day-old rats by using a hemagglutinating virus of Japan (HVJ)-liposome mediated gene transfer technique. "
|8.||Proteins (Proteins, Gene)
|9.||Phosphopyruvate Hydratase (Enolase)
|1.||Drug Therapy (Chemotherapy)